linked in pixel

Dr. Daniel Johnson is a medical oncologist at Ochsner MD Anderson Cancer Center. He specializes in treating patients with melanoma with specific research interests in strategies to overcome immunotherapy resistance and prevent immunotherapy related toxicities. He has multiple peer-reviewed articles and presentations at national meetings pertaining to the management and underlying mechanisms of immune toxicity. Dr. Johnson is a clinical investigator focusing on designing and implementing clinical trials intended to optimize the safety and efficacy of immune checkpoint inhibitors.

Medical Education

Lousiana St Univ at New Orleans Med School
Field of Study: Medicine

Internship

Louisiana State University School of Medicine in New Orleans
Field of Study: Internal Medicine

Residency

Louisiana State University School of Medicine in New Orleans
Field of Study: Internal Medicine

Fellowship

University of Texas M.D. Anderson Cancer Center
Field of Study: Hematology and Oncology

  • American Board of Internal Medicine